Skip to main content
. 2022 Mar 27;14(7):1394. doi: 10.3390/nu14071394

Table 2.

Univariable Cox regression analysis for MACE in Patients with AMI.

Characteristic HR (95% CI) p-Value
Ages, years 1.034 (1.016–1.051) <0.001
Females, % 2.168 (1.405–3.346) <0.001
New AMI, % 1.049 (0.600–1.837) 0.866
Previous histories
 Stroke, % 1.311 (0.712–2.417) 0.385
 Hypertension, % 0.872 (0.568–1.341) 0.534
 Diabetes, % 1.295 (0.811–2.068) 0.279
 Smoking, % 0.535 (0.349–0.822) 0.004
Systolic BP, mmHg 1.001 (0.991–1.011) 0.888
Diastolic BP, mmHg 0.994 (0.979–1.010) 0.473
Heart rate, beats/min 1.008 (0.996–1.020) 0.210
Creatinine, µmol/L 1.000 (0.999–1.000) 0.718
Total cholesterol, mmol/L 0.993 (0.963–1.024) 0.649
Low-density lipoprotein, mmol/L 0.965 (0.781–1.193) 0.745
High-density lipoprotein, mmol/L 0.956 (0.800–1.142 0.618
Triglycerides, mmol/L 0.892 (0.768–1.035) 0.132
Fasting glucose, mmol/L 1.036 (0.966–1.111) 0.328
Cardiac Troponins I, μg/L 1.000 (0.999–1.001) 0.528
ST-segment elevation, % 1.176 (0.766–1.805) 0.460
Killip II/III class, % 2.313 (1.323–4.044) 0.003
PCI, % 0.831 (0.523–1.320) 0.432
Medical treatment
 Aspirin, % 0.408 (0.178–0.937) 0.034
 Statin, % 0.309 (0.149–0.641) 0.002
 Clopidogrel, % 1.241 (0.768–2.005) 0.377
 Beta-blocker, % 0.591 (0.385–0.908) 0.016
 Ticagrelor, % 0.572 (0.336–0.975) 0.040
 ACEI/ARB, % 0.814 (0.529–1.251) 0.348

HR hazard ratio, CI confidence interval, MACE major adverse cardiac events, other abbreviations as in Table 1.